Details of the Drug

General Information of Drug (ID: DMFYEGD)

• Drug Name: JM-010

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]

• Cross-matching ID: TTD ID: DUF48L

References

• [1] ClinicalTrials.gov (NCT04377945) A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study in Parkinson's Disease Patients With Dyskinesia to Assess the Efficacy and Safety/Tolerability of Fixed Dose Combinations of JM-010 and Its Individual Components. U.S.National Institutes of Health.